Ironwood Pharmaceuticals Inc IRWD:NASDAQ

Earnings Announcement Next Earnings date is expected on 07/30/2019
Last Price$10.92NASDAQ Closing Price as of 4:00PM ET 7/23/19

Today's Change-0.04(0.36%)
Bid (Size)$10.92 (279)
Ask (Size)$11.20 (20)
Day Low / High$10.84 - 11.14
Volume1.5 M
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 07/23/2019

 

Ironwood Pharmaceuticals Inc ( NASDAQ )

Price: $10.92
Change: -0.04 (0.36%)
Volume: 1.5 M
4:00PM ET 7/23/2019
 
 

Supernus Pharmaceuticals Inc ( NASDAQ )

Price: $32.08
Change: -0.01 (0.03%)
Volume: 274.2 K
4:00PM ET 7/23/2019
 
 

Prestige Consumer Healthcare Inc ( NYSE )

Price: $32.66
Change: +0.51 (1.59%)
Volume: 238.5 K
4:02PM ET 7/23/2019
 
 

Pacira Biosciences Inc ( NASDAQ )

Price: $40.00
Change: +0.36 (0.91%)
Volume: 447.6 K
4:00PM ET 7/23/2019
 
 

Portola Pharmaceuticals Inc ( NASDAQ )

Price: $27.00
Change: +0.29 (1.09%)
Volume: 550.1 K
4:00PM ET 7/23/2019
 

Read more news Recent News

Analyst Actions: Credit Suisse Starts Ironwood Pharmaceuticals at Neutral
11:54AM ET 7/10/2019 MT Newswires

Ironwood Pharmaceuticals' (IRWD) average rating among analysts is a hold, with an average price target of $15. Price: 10.39, Change: +0.03, Percent Change:...

After Hours Watch List Scorecard: IRWD, QUIK, SESN
5:14PM ET 6/19/2019 MT Newswires

Here's how the stocks on Tuesday's After Hours Watch List performed during today's regular session AFTER HOURS REGULAR SESSION IRWD ...

Sector Update: Health Care Stocks Lead Markets to Modest Rise
3:52PM ET 6/19/2019 MT Newswires

Top Health Care Stocks JNJ +0.09% PFE +0.19% ABT +0.31% MRK +0.17% AMGN +0.07% Health care stocks extended their prior gains, including a nearly 1.0%...

Sector Update: Health Care Stocks Rising in Defensive Session
1:36PM ET 6/19/2019 MT Newswires

Top Health Care Stocks JNJ +0.09% PFE +0.19% ABT +0.31% MRK +0.17% AMGN +0.07% Health care stocks were moderately higher this afternoon, including a...

View all Commentary and Analysis

Ironwood Pharmaceuticals (IRWD) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
9:32AM ET 7/23/2019 Zacks

Ironwood (IRWD) possesses the right combination of the two key ingredients for a likely earnings...

Assertio Therapeutics' Turnaround Is At A Complete Stop, Value Investors Beware
8:56AM ET 7/10/2019 Seeking Alpha

Ironwood Pharmaceuticals, Inc. (IRWD) CEO Mark Mallon on Q1 2019 Results - Earnings Call Transcript
1:20AM ET 5/05/2019 Seeking Alpha

Ironwood Pharmaceuticals, Inc. 2019 Q1 - Results - Earnings Call Slides
10:19AM ET 5/02/2019 Seeking Alpha

Company Profile

Business DescriptionIronwood Pharmaceuticals, Inc. is a commercial biotechnology company, which engages in the discovery, commercialization, and development of medicines. Its products include linaclotide, a guanylate cyclase type-C agonist which treats patients irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook Jr., and Gina Bornino Miller in 1998 and is headquartered in Cambridge, MA. View company web site for more details
Address301 Binney Street
Cambridge, Massachusetts 02142
Phone+1.617.621.7722
Number of Employees515
Recent SEC Filing07/22/20198-K
Chief Executive Officer & DirectorMark Mallon
PresidentThomas A. McCourt
Chief Financial Officer & Senior Vice PresidentGina R. Consylman
Chief Medical Officer & Senior Vice PresidentMichael Shetzline

Company Highlights

Price Open$10.95
Previous Close$10.96
52 Week Range$9.07 - 20.17
Market Capitalization$1.7 B
Shares Outstanding155.6 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement07/30/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.29
Beta vs. S&P 500N/A
Revenue$346.6 M
Net Profit Margin-86.22%
Return on Equity176.95%

Analyst Ratings as of 07/12/2019

Buy
4
Overweight
0
Hold
6
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset